Assay Method for the Analgesic Nucynta
Tapentadol can be a problematic compound for HPLC analysis due to the Amine functional group. Tertiary amines are often particularly difficult to obtain a good peak shape using Reversed Phase methods. Peak tailing has been reported in several published papers in the literature.
With this Method, a sharp Peak is obtained due to the unique retention mode. Data from two column lots shown in the figure illustrates the reproducibility of the Method and its robustness.
Peak:
Tapentadol HCI
Method Conditions
Column: Cogent Diamond Hydride™, 4µm, 100Å
Catalog No.: 70000-7.5P
Dimensions: 4.6 x 75mm
Mobile Phase:
—A: DI Water / 0.1% Formic Acid (v/v)
—B: Acetonitrile / 0.1% Formic Acid (v/v)
Gradient:
Time (minutes) | %B |
0 | 95 |
1 | 95 |
6 | 40 |
7 | 95 |
Post Time: 3 minutes
Injection vol.: 1µL
Flow rate: 1.0mL / minute
Detection: UV @ 271nm
Sample Preparation: 75mg strength Nucynta® tablet was ground and weighed in a 25mL volumetric flask. A portion of 50:50 Solvent A / Solvent B diluent was added and the flask was sonicated 10 minutes. It was then diluted to mark and filtered with a 0.45µm Nylon Syringe Filter (MicroSolv Tech Corp.). The filtrate was diluted 1:5 for HPLC injections.
t0: 0.9 minutes
Note: Tapentadol is an analgesic compound used to treat moderate to severe pain. Its efficacy is due to two modes of action: one is an agonist of the µ-opioid receptor and another as a norepinephrine reuptake inhibitor.
Attachment
No 234 Nucynta Tapentadol HCl Tablet Analyzed with HPLC pdf 0.3 Mb Download File